- Home
- DBD vs OMCL Comparison
DBD vs OMCL Comparison
Compare DBD & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBD
- OMCL
- Stock Information
- Founded
- DBD 1859
- OMCL 1992
- Country
- DBD United States
- OMCL United States
- Employees
- DBD N/A
- OMCL N/A
- Industry
- DBD EDP Services
- OMCL Computer Manufacturing
- Sector
- DBD Technology
- OMCL Technology
- Exchange
- DBD Nasdaq
- OMCL Nasdaq
- Market Cap
- DBD 1.6B
- OMCL 1.8B
- IPO Year
- DBD N/A
- OMCL 2001
- Fundamental
- Price
- DBD $44.41
- OMCL $39.72
- Analyst Decision
- DBD Strong Buy
- OMCL Buy
- Analyst Count
- DBD 2
- OMCL 6
- Target Price
- DBD $57.50
- OMCL $52.33
- AVG Volume (30 Days)
- DBD 115.0K
- OMCL 455.8K
- Earning Date
- DBD 02-12-2025
- OMCL 02-06-2025
- Dividend Yield
- DBD N/A
- OMCL N/A
- EPS Growth
- DBD N/A
- OMCL N/A
- EPS
- DBD N/A
- OMCL 0.27
- Revenue
- DBD $3,751,100,000.00
- OMCL $1,112,238,000.00
- Revenue This Year
- DBD $2.00
- OMCL $4.02
- Revenue Next Year
- DBD $1.62
- OMCL $4.32
- P/E Ratio
- DBD N/A
- OMCL $147.11
- Revenue Growth
- DBD N/A
- OMCL N/A
- 52 Week Low
- DBD $30.37
- OMCL $25.12
- 52 Week High
- DBD $51.81
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- DBD 49.50
- OMCL 38.90
- Support Level
- DBD $40.31
- OMCL $39.23
- Resistance Level
- DBD $46.69
- OMCL $40.50
- Average True Range (ATR)
- DBD 1.70
- OMCL 2.04
- MACD
- DBD 0.08
- OMCL -0.21
- Stochastic Oscillator
- DBD 54.74
- OMCL 14.21
About DBD Diebold Nixdorf Incorporated Common stock
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are banking which offers integrated solutions for financial institutions and retail which offers solutions, software, and services which improve the checkout process for retailers.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.